Emma Reeve Ptc Therapeutics, Inc. (PTCT) insider trading activity

Emma Reeve is of PTC THERAPEUTICS, INC.. Currently has a direct ownership of 6,666 shares of PTCT, which is worth approximately $501,949. The most recent transaction as insider was on Dec 03, 2025, when has been sold 733 shares (Common Stock) at a price of $78.62 per share, resulting in proceeds of $57,628. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.67K

35.48% 3M change

40.48% 12M change

Total Value Held $501,949

Emma Reeve Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 03 2025	SELL Open market or private sale	$57,628 $78.62 p/Share	733 Reduced 9.91%	6,666 Common Stock
Dec 03 2025	BUY Exercise of conversion of derivative security	$34,113 $46.54 p/Share	733 Added 9.01%	7,399 Common Stock
Nov 21 2025	SELL Open market or private sale	$795,000 $79.5 p/Share	10,000 Reduced 60.0%	6,666 Common Stock
Nov 21 2025	BUY Exercise of conversion of derivative security	$511,599 $51.16 p/Share	10,000 Added 37.5%	16,666 Common Stock
Nov 12 2025	SELL Open market or private sale	$546,308 $74.5 p/Share	7,333 Reduced 52.38%	6,666 Common Stock
Nov 12 2025	BUY Exercise of conversion of derivative security	$341,277 $46.54 p/Share	7,333 Added 34.38%	13,999 Common Stock
Oct 30 2025	SELL Open market or private sale	$1,088,787 $69.5 p/Share	15,666 Reduced 70.15%	6,666 Common Stock

Oct 30 2025	BUY Exercise of conversion of derivative security	$457,200 $38.1 p/Share	12,000 Added 39.13%	18,666 Common Stock
Oct 03 2025	SELL Open market or private sale	$1,687,603 $66.02 p/Share	25,562 Reduced 71.22%	10,332 Common Stock
Oct 03 2025	BUY Exercise of conversion of derivative security	$903,872 $35.36 p/Share	25,562 Added 57.39%	18,982 Common Stock
Sep 11 2025	SELL Open market or private sale	$934,447 $59.5 p/Share	15,705 Reduced 60.32%	10,332 Common Stock
Sep 11 2025	BUY Exercise of conversion of derivative security	$321,425 $29.66 p/Share	10,837 Added 49.25%	11,169 Common Stock
Jan 03 2025	BUY Grant, award, or other acquisition	-	4,000 Added 20.83%	15,200 Common Stock
Feb 15 2024	BUY Grant, award, or other acquisition	-	4,000 Added 26.32%	11,200 Common Stock
May 23 2023	SELL Open market or private sale	$157,873 $59.53 p/Share	2,652 Reduced 26.92%	7,200 Common Stock
May 23 2023	BUY Exercise of conversion of derivative security	$88,656 $33.43 p/Share	2,652 Added 23.56%	8,602 Common Stock
May 22 2023	SELL Open market or private sale	$423,615 $59.53 p/Share	7,116 Reduced 49.71%	7,200 Common Stock
May 22 2023	BUY Exercise of conversion of derivative security	$237,887 $33.43 p/Share	7,116 Added 38.96%	11,148 Common Stock
Apr 21 2023	SELL Open market or private sale	$239,381 $55.31 p/Share	4,328 Reduced 37.54%	7,200 Common Stock
Jan 05 2023	BUY Grant, award, or other acquisition	-	4,000 Added 25.76%	11,528 Common Stock
Jan 07 2022	BUY Grant, award, or other acquisition	-	3,200 Added 29.83%	7,528 Common Stock
Jan 06 2021	BUY Grant, award, or other acquisition	-	1,650 Added 27.6%	4,328 Common Stock
Dec 15 2020	BUY Exercise of conversion of derivative security	$33,945 $33.02 p/Share	1,028 Added 27.74%	2,678 Common Stock
Dec 14 2020	SELL Open market or private sale	$134,096 $68.0 p/Share	1,972 Reduced 54.45%	1,650 Common Stock
Dec 14 2020	BUY Exercise of conversion of derivative security	$65,115 $33.02 p/Share	1,972 Added 42.93%	2,622 Common Stock

Also insider at

CNST

CONSTELLATION PHARMACEUTICALS INC Healthcare

Chief Financial Officer

EDIT

Editas Medicine, Inc. Healthcare

Director

AADI

Aadi Bioscience, Inc. Healthcare

Emma Reeve

South Plainfield, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PTCT shares.

Notify only if

Value

Insider Trading

Get notified when an Ptc Therapeutics, Inc. insider buys or sells PTCT shares.

Notify only if

Operation

Value

Type

News

Receive news related to PTC THERAPEUTICS, INC.

Track Activities on PTCT

Account